Evidence map›Paper›PMID 33110608›Full record

ArticleJournal of pharmaceutical policy and practice2020

Prescription opioid dispensing in Canada: an update on recent developments to 2018.

Wayne Jones, Lenka Vojtila, Paul Kurdyak, Benedikt Fischer

Open access · goldAbstract read
In one paragraph

Article in Journal of pharmaceutical policy and practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Trends in prescription opioid use for pain in Canada: a population-based repeated cross-sectional study of 6 provinces.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Strategies to prevent long-term opioid use following trauma: a Canadian practice survey.Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Opioid use trends in Spain: the case of the island of La Gomera (2016-2019).Naunyn-Schmiedeberg's archives of pharmacology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 3 countries.

Wayne JonesCentre for Applied Research in Mental Health and Addiction (CARMHA), Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada.
Lenka VojtilaCentre for Addiction and Mental Health, 33 Russell Street, Toronto, Ontario Canada.
Paul KurdyakCentre for Addiction and Mental Health, 33 Russell Street, Toronto, Ontario Canada.
Benedikt FischerCentre for Applied Research in Mental Health and Addiction (CARMHA), Faculty of Health Sciences, Simon Fraser University, Vancouver, Canada.ORCID 0000-0002-2186-4030
Centre for Addiction and Mental Health · CASimon Fraser University · CAUniversity of Auckland · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Canada has been home to comparatively extreme developments in prescription opioid (PO) availability and related harms (e.g. morbidity, mortality) post-2000. Following persistent pan-Canadian increases in PO use, select control measures were implemented and PO dispensing levels-while only inconsistently by province-inverted, and began to plateau or decrease post-2012. We examined annual PO dispensing levels in Canada up until 2018, based on representative prescription sample data from community-based retail pharmacies. Annual prescription-based dispensing data were converted into defined daily doses/1000 population/day by province, and mainly categorized into 'weak' and 'strong' opioids. All provinces indicated decreasing trends in strong PO levels in most recent years, yet with inter-provincial differences of up to one magnitude in 2018; in about half the provinces, dispensing fell to below-2005 levels. British Columbia had the largest decline in strong PO dispensing from its peak rate (- 48.5%) in 2011. Weak opioid dispensing trends remained more inconsistent and bifurcated across Canada. The distinct effects of individual-including many provincially initiated and governed-PO control measures urgently need to be evaluated. In the meantime, recent reductions in general PO availability across Canada appear to have contributed to shortages in opioid supply for existent, sizable (including non-medical) user populations and may have contributed to recent marked increases in illicit opioid use and harms (including rising deaths).

Indexed as

CanadaDispensingInterventionsOpioidsPublic health

Identifiers

PMID33110608
PMCPMC7583232
OpenAlexW3094506985

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.